United Therapeutics Corporation — Operating Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/71902dfe-412c-4eb1-9715-d709089eb093/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.5B | 2025-01-01 – 2025-12-31 | evidence 0001082554-26-000006 |
| FY 2024 | $1.4B | 2024-01-01 – 2024-12-31 | evidence 0001082554-25-000005 |
| FY 2023 | $1.2B | 2023-01-01 – 2023-12-31 | evidence 0001082554-24-000005 |
| FY 2022 | $979.7M | 2022-01-01 – 2022-12-31 | evidence 0001082554-23-000005 |
| FY 2021 | $555.9M | 2021-01-01 – 2021-12-31 | evidence 0001082554-22-000004 |
| FY 2020 | $593.6M | 2020-01-01 – 2020-12-31 | evidence 0001082554-21-000008 |
| FY 2019 | $-187.6M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-025009 |
| FY 2018 | $805.4M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-000724 |
| FY 2017 | $814.9M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-000911 |
| FY 2016 | $1.1B | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-000802 |
| FY 2015 | $699.0M | 2015-01-01 – 2015-12-31 | evidence 0001047469-17-000802 |
| FY 2014 | $538.8M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001069 |
| FY 2013 | $292.5M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-001267 |
| FY 2012 | $421.6M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001660 |
| FY 2011 | $317.8M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-001646 |
| FY 2010 | $171.3M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-001646 |
| FY 2009 | $25.8M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-001646 |
| FY 2008 | $-82.1M | 2008-01-01 – 2008-12-31 | evidence 0001047469-11-001229 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
United Therapeutics Corporation — all facts · Revenue · Net Income